20th World Congress of Dermatology
?

Searching by Author's name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Results of searching?: Christophers?E.

SA0004
The therapeutic response to intermittent IM alefacept: post-dosing effect
IC0342
The E. coli-selective antimicrobial protein psoriasin kills E. coli by zinc-depletion
IC1394
Are autoantibodies to the high-affinity IgE receptor relevant for chronic urticaria?
IC1409
Alefacept improves psoriasis and quality of life: results of an international trial
PL1601
Psoriasis
P0650
The international scop-network (skin care in organ transplant patients): analysis of risk factors, prophylactical strategies and therapeutical options
P0843
Serum levels of the chemokine IP-10 are elevated in inflammatory skin disorders
P0844
RNASE 7 in inflammatory skin disease: an immunohistochemical study
P1011
Atypical herpes zoster in a kidney transplant patient
P1991
Alefacept provides long-lasting, durable remissions in patients with psoriasis
P1993
Safety profile of alefacept: pooled results of placebo-controlled trials
P2016
Long-term safety of cyclosporin (Cy-A) in the treatment of psoriasis: a 5 year cohort study
P2017
Incidence of malignancy during oral cyclosporin (Cy-A) treatment of severe psoriasis
P2152
Successful treatment of multiple actinic keratoses with imiquimod 5% in organ transplant patients


1st TO 5th JULY 2002
PARIS


Back to main menu

Foreword

Oral communications and co-opted speakers abstracts

Poster abstracts

Searching by Author's name

Searching by Article's number

?